The IPOL market is witnessing steady growth over the forecast period, supported by continued eradication surveillance, expansion of adult booster programs.
Read More
The Iplex market is witnessing steady growth over the forecast period, supported by improved diagnosis of growth disorders, expansion of pediatric endocrinology services.
Read More
The Intron A Or Alfatronol market is witnessing steady growth over the forecast period, supported by declining but stable demand in niche indications, continued use in combination regimens.
Read More
The Insuman market is witnessing steady growth over the forecast period, supported by increasing type 2 diabetes incidence, expanding access in emerging markets.
Read More
The Inmazeb market is witnessing steady growth over the forecast period, supported by ongoing outbreak preparedness, expansion of infectious disease funding.
Read More
The Inflectra market is witnessing steady growth over the forecast period, supported by biosimilar friendly regulations, expanding patient access to biologics.
Read More
The Infergen market is witnessing steady growth over the forecast period, supported by shift toward direct acting antivirals, niche demand in resistant cases.
Read More
The Infasurf market is witnessing steady growth over the forecast period, supported by rising global preterm births, growth in neonatal healthcare spending.
Read More
The Infanrix And Infanrix-hexa market is witnessing steady growth over the forecast period, supported by increasing birth rates in emerging economies, expansion of universal immunization coverage.
Read More
The Increlex market is witnessing steady growth over the forecast period, supported by expansion of personalized pediatric growth treatments, rising investments in rare disease therapies.
Read More